Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17–92 Cluster in Endothelial Cells
- 1 March 2013
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 33 (3), 533-543
- https://doi.org/10.1161/atvbaha.112.300415
Abstract
Objective—Histone deacetylases (HDACs) modulate gene expression by deacetylation of histone and nonhistone proteins. Several HDACs control angiogenesis, but the role of HDAC9 is unclear. Methods and Results—Here, we analyzed the function of HDAC9 in angiogenesis and its involvement in regulating microRNAs. In vitro, silencing of HDAC9 reduces endothelial cell tube formation and sprouting. Furthermore, HDAC9 silencing decreases vessel formation in a spheroid-based Matrigel plug assay in mice and disturbs vascular patterning in zebrafish embryos. Genetic deletion of HDAC9 reduces retinal vessel outgrowth and impairs blood flow recovery after hindlimb ischemia. Consistently, overexpression of HDAC9 increases endothelial cell sprouting, whereas mutant constructs lacking the catalytic domain, the nuclear localization sequence, or sumoylation site show no effect. To determine the mechanism underlying the proangiogenic effect of HDAC9, we measured the expression of the microRNA (miR)-17–92 cluster, which is known for its antiangiogenic activity. We demonstrate that silencing of HDAC9 in endothelial cells increases the expression of miR-17–92. Inhibition of miR-17–20a rescues the sprouting defects induced by HDAC9 silencing in vitro and blocking miR-17 expression partially reverses the disturbed vascular patterning of HDAC9 knockdown in zebrafish embryos. Conclusion—We found that HDAC9 promotes angiogenesis and transcriptionally represses the miR-17–92 cluster.Keywords
This publication has 43 references indexed in Scilit:
- Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactinThe EMBO Journal, 2011
- Histone deacetylases: anti-angiogenic targets in cancer therapy.Current Cancer Drug Targets, 2010
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular FunctionsScience, 2009
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapyCancer Letters, 2008
- Histone Deacetylase 7 Silencing Alters Endothelial Cell Migration, a Key Step in AngiogenesisCirculation Research, 2007
- Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10Cell, 2006
- Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589Clinical Cancer Research, 2006
- Inhibitors of Histone Deacetylation Downregulate the Expression of Endothelial Nitric Oxide Synthase and Compromise Endothelial Cell Function in Vasorelaxation and AngiogenesisCirculation Research, 2002
- Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genesNature Medicine, 2001
- Histone deacetylases: complex transducers of nuclear signalsSeminars in Cell & Developmental Biology, 1999